ArticleBMC pulmonary medicine2021
Modified silicone stent for the treatment of post-surgical bronchopleural fistula: a clinical observation of 17 cases.
Article in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 12 citations in OpenAlex.
- Chinese expert consensus on the diagnosis and management of bronchopleural fistula after pulmonary resection (2026 edition).Journal of thoracic disease · 2026Review
- A pilot study of endobronchial repairment for bronchopleural fistulas.Respiratory research · 2025Article
- Developing an innovative interventional approach for stenting trachea.BMJ surgery, interventions, & health technologies · 2025Article
- Treatment of intractable bronchopleural fistula with a one-side-closed silicone stent using retrograde approach: A case report.Respiratory medicine case reports · 2024Article
- A 3D-engineered silicone stent to treat a refractory bronchopleural fistula.ERJ open research · 2023Article
- Progress Report on Interventional Treatment for Bronchopleural Fistula.Emergency medicine international · 2023Review
- The therapeutic effect of stem cells from human exfoliated deciduous teeth on a rat model of tracheal fistula.Stem cell research & therapy · 2022Article
- Multiple bronchopleural fistulas resolved with combination stent therapy.Annals of thoracic medicineArticle
- Bronchoscopic interventions for bronchopleural fistulas.Therapeutic advances in respiratory diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchopleural fistula is a rare but life-threatening event with limited therapeutic options. We aimed to investigate the efficacy and safety of the modified silicone stent in patients with post-surgical bronchopleural fistula.
methodsBetween March 2016 and April 2020, we retrospectively reviewed the records of 17 patients with bronchopleural fistula and who underwent bronchoscopic placement of the Y-shaped silicone stent. The rate of initial success, clinical success and clinical cure, and complications were analyzed.
resultsStent placement was successful in 16 patients in the first attempt (initial success rate: 94.1%). The median follow-up time was 107 (range, 5-431) days. All patients achieved amelioration of respiratory symptoms. The clinical success rate was 76.5%. Of the 14 patients with empyema, the daily drainage was progressively decreased in 11 patients, and empyema completely disappeared in six patients. Seven stents were removed during follow-up: four (26.7%) for the cure of fistula, two for severe proliferation of granulomatous tissue and one for stent dislocation. No severe adverse events (i.e. massive hemoptysis, suture dehiscence) took place. Seven patients died (due to progression of malignancy, uncontrolled infection, myocardial infarction and left heart failure).
conclusionsThe modified silicone stent may be an effective and safe option for patients with post-surgical bronchopleural fistula patients in whom conventional therapy is contraindicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.